Search - tctmd.com

Displaying 241 - 260 of 475

Sort: Relevancy | Date

Presentation TCT 2016

BRS Snapshots: Renuvia FAST

Presenter: Ron Waksman, Robert-Jan van Geuns, Ian T. Meredith

October 31, 2016

Presentation TCT 2016

NeoVas PLLA-Based Sirolimus-Eluting Scaffold: Early Results and Phase III Completion

Presenter: Ron Waksman, Robert-Jan van Geuns, Guosheng Fu

October 31, 2016

Presentation TCT 2016

From APTITUDE to MAGNITUDE: Progress Towards the Development of a Thin-walled Novel PLLA-based Polymeric BRS

Presenter: Ron Waksman, Robert-Jan van Geuns, Juan F. Granada

October 31, 2016

Presentation TCT 2016

FIRESORB PLLA-Based Sirolimus-Eluting Scaffold: 6-Month FUTURE-I Results

Presenter: Ron Waksman, Robert-Jan van Geuns, Bo Xu

October 31, 2016

Presentation TCT 2016

MIRAGE: Design Novelty and 1-Year Results With a Microfiber-Based BRS

Presenter: Ron Waksman, Robert-Jan van Geuns, Patrick W. Serruys

October 31, 2016

Presentation TCT 2016

Case #3: A Novel Issue With a Bioresorbable Scaffold

Presenter: Antonio Colombo, Jeffrey W. Moses, Carlo Di Mario

October 31, 2016

Presentation TCT 2016

AMS/Dreams Evolution to Magmaris: Latest Outcomes With Magnesium-Based Stents

Presenter: Ron Waksman, Robert-Jan van Geuns, Michael Haude

October 31, 2016

Presentation TCT 2016

Case #2: A Novel Issue With a Bioresorbable Scaffold

Presenter: Antonio Colombo, Jeffrey W. Moses, Azeem Latib

October 31, 2016

Presentation TCT 2016

MeRes100 Design Specifications and the 6-months MeRes-1 Results

Presenter: Ron Waksman, Robert-Jan van Geuns, Ashok Seth

October 31, 2016

Presentation TCT 2016

FANTOM: Novel Design Attributes and 6-Month FANTOM II Results

Presenter: Ron Waksman, Robert-Jan van Geuns, Jose de Ribamar Costa Jr

October 31, 2016

Presentation TCT 2016

Case #1: A Novel Issue With a Bioresorbable Scaffold

Presenter: Antonio Colombo, Jeffrey W. Moses, Patrick W. Serruys

October 31, 2016

Presentation TCT 2016

Desolve Nx, Cx and Amity: Unique Properties and Results From 150 Um To 120 Um

Presenter: Ron Waksman, Robert-Jan van Geuns, Alexandre Abizaid

October 31, 2016

Presentation TCT 2016

Bioresorbable Vascualr Scaffolds: The Future of PCI?

Presenter: Vinay K. Bahl, Amal Kumar Banerjee, Jamshed J. Dalal, Narenda N. Khanna, Ajay J. Kirtane, C. Venkata S. Ram, Kamal K. Sethi, Sundeep Mishra

October 31, 2016

Presentation TCT 2016

The Great Absorb Debate: Is Absorb Ready To Be Used In Most Patients And Lesions? No Short-Term Data Is Borderline, Procedures Are More Costly And Complex, And Long-Term Data Is Scant Best To Wait!

Presenter: Stephen G. Ellis, Corrado Tamburino, Daniel I. Simon

October 31, 2016

News Conference News TCT 2016

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

Yael L. Maxwell

October 31, 2016

Presentation TCT 2016

The Great Absorb Debate: Is Absorb Ready To Be Used In Most Patients And Lesions? Yes With Proper Technique And Planning, Nearly All PCI Patients Can Benefit From BVS!

Presenter: Stephen G. Ellis, Corrado Tamburino, Massimo Napodano

October 31, 2016

Presentation TCT 2016

Outcome Registries VII: IT-DISAPPEARS

Presenter: Stephen G. Ellis, Corrado Tamburino, Anna Sonia Petronio

October 31, 2016

Presentation TCT 2016

Outcome Registries VI: France ABSORB

Presenter: Stephen G. Ellis, Corrado Tamburino, Didier Carrié

October 31, 2016

Presentation TCT 2016

Outcome Registries V: New Insights From GHOST

Presenter: Stephen G. Ellis, Corrado Tamburino

October 31, 2016

Presentation TCT 2016

Outcome Registries IV: The UK Absorb Registry

Presenter: Stephen G. Ellis, Corrado Tamburino, Andreas Baumbach

October 31, 2016

Advertisement

BRS Snapshots: Renuvia FAST

NeoVas PLLA-Based Sirolimus-Eluting Scaffold: Early Results and Phase III Completion

From APTITUDE to MAGNITUDE: Progress Towards the Development of a Thin-walled Novel PLLA-based Polymeric BRS

FIRESORB PLLA-Based Sirolimus-Eluting Scaffold: 6-Month FUTURE-I Results

MIRAGE: Design Novelty and 1-Year Results With a Microfiber-Based BRS

Case #3: A Novel Issue With a Bioresorbable Scaffold

AMS/Dreams Evolution to Magmaris: Latest Outcomes With Magnesium-Based Stents

Case #2: A Novel Issue With a Bioresorbable Scaffold

MeRes100 Design Specifications and the 6-months MeRes-1 Results

FANTOM: Novel Design Attributes and 6-Month FANTOM II Results

Case #1: A Novel Issue With a Bioresorbable Scaffold

Desolve Nx, Cx and Amity: Unique Properties and Results From 150 Um To 120 Um

Bioresorbable Vascualr Scaffolds: The Future of PCI?

The Great Absorb Debate: Is Absorb Ready To Be Used In Most Patients And Lesions? No Short-Term Data Is Borderline, Procedures Are More Costly And Complex, And Long-Term Data Is Scant Best To Wait!

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

The Great Absorb Debate: Is Absorb Ready To Be Used In Most Patients And Lesions? Yes With Proper Technique And Planning, Nearly All PCI Patients Can Benefit From BVS!

Outcome Registries VII: IT-DISAPPEARS

Outcome Registries VI: France ABSORB

Outcome Registries V: New Insights From GHOST

Outcome Registries IV: The UK Absorb Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content